Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study
- Anthony R. Mato
- , Lisa M. Hess
- , Yongmei Chen
- , Paolo B. Abada
- , Heiko Konig
- , John M. Pagel
- , Richard A. Walgren
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations